A prescription weight-loss drug embraced by celebrities now has the green light in New Zealand

Wegovy injections limit appetite and reduce food cravings.

It will cost patients between 600-and-one thousand dollars a month - and will be used to target obesity here as soon as possible.

One in three Kiwi adults are obese.

Calocurb CEO Sarah Kennedy says it's a useful development as one more tool for doctors to use.